ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 0398

Chest CT Ordering Practices at Expert Scleroderma Centers in the United States

Elana Bernstein1, John VanBuren2, Shervin Assassi3, Flavia Castelino4, Lorinda Chung5, Chase Correia6, Luke Evnin7, Tracy Frech8, Emily Startup2, Jessica Gordon9, Faye Hant10, Laura Hummers11, Nora Sandorfi12, Ami Shah13, Victoria Shanmugam14, Virginia Steen15 and Dinesh Khanna16, 1Columbia University, New York, NY, 2University of Utah, Salt Lake City, UT, 3University of Texas Houston McGovern Medical School, Division of Rheumatology and Clinical Immunogenetics, Houston, TX, 4Massachusetts General Hospital/Harvard Medical School, Boston, MA, 5Stanford University School of Medicine and Palo Alto VA Health Care System, Palo Alto, CA, 6Northwestern University, Chicago, IL, 7Scleroderma Research Foundation, Brisbane, CA, 8University of Utah and Salt Lake Veterans Affair Medical Center, Salt Lake City, UT, 9Hospital for Special Surgery, New York, NY, 10Medical University of South Carolina, Charleston, SC, 11Johns Hopkins Univerisity, Ellicott City, MD, 12University of Pennsylvania, Philadelphia, PA, 13Johns Hopkins University School of Medicine, Ellicott City, MD, 14The George Washington University, Washington, DC, 15Division of Rheumatology, Department of Medicine, MedStar Georgetown University Hospital, Washington, DC, 16University of Michigan, Ann Arbor, MI

Meeting: ACR Convergence 2020

Keywords: Computed tomography (CT), interstitial lung disease, pulmonary, Scleroderma, Systemic sclerosis

  • Tweet
  • Email
  • Print
Save to PDF
Session Information

Date: Friday, November 6, 2020

Session Title: Systemic Sclerosis & Related Disorders – Clinical Poster I

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Interstitial lung disease (ILD) is the leading cause of death in patients with systemic sclerosis (SSc). Although pulmonary function tests (PFTs) are commonly used to screen for ILD in patients with SSc, studies have shown that they lack sensitivity for the detection of ILD. Moreover, although high resolution computed tomography (HRCT) scan of the chest is the gold standard test for detection of ILD, there is no consensus among rheumatologists regarding the use of HRCT to screen for ILD in their SSc patients. The aims of this study were to describe the HRCT ordering practices at expert SSc centers in the US, and to determine which patient characteristics are associated with HRCT ordering.

Methods: We performed a retrospective cohort study of patients enrolled in the Collaborative National Quality and Efficacy Registry (CONQUER) at 13 sites in the US between June 6, 2018, and February 1, 2020. CONQUER is a US-based, multicenter cohort of adults with SSc who met 2013 ACR/EULAR Classification Criteria and had a disease duration ≤5 years from the 1st non-Raynaud’s symptom at enrollment. We used the Student’s t test, chi square test, and Fisher’s exact test, as appropriate, to compare baseline characteristics between participants who did and did not undergo HRCT. We performed univariate logistic regression (LR) followed by multivariable LR to determine which patient characteristics were associated with HRCT ordering. Each variable that attained a p-value< 0.1 in the univariate analysis was included in the final multivariable LR model, as were age and sex. Statistical significance in the univariate and multivariable models was defined as a p-value< 0.05.

Results: 356 SSc patients were enrolled in CONQUER, of whom 285 (80%) underwent HRCT at some point during their SSc disease course. Among those who underwent HRCT compared to those who did not, a smaller proportion were centromere positive (9.5% vs. 22.5%) and a greater proportion had crackles on exam (23.5% vs. 9.9%). SSc patients who underwent HRCT had lower forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1), and diffusion capacity for carbon monoxide (DLCO) than those who did not (Table 1). In univariate analyses, the following variables were statistically significantly associated with HRCT ordering: crackles on pulmonary exam, FVC< 80%, FEV1< 80%, total lung capacity (TLC)< 80%, missing TLC%, and DLCO< 60% (Table 2). A positive centromere antibody was negatively associated with HRCT ordering. In the final multivariable LR model, positive centromere antibody remained negatively associated and missing TLC% remained positively associated with HRCT ordering (Table 3).

Conclusion: 80% of SSc patients enrolled in CONQUER at 13 expert SSc centers in the US underwent HRCT. Abnormal PFTs and crackles were associated with HRCT ordering in univariate analyses. However, in the multivariable analysis, only a positive centromere antibody remained associated with a decreased odds of HRCT ordering and a missing TLC% remained associated with an increased odds of HRCT ordering. Given the poor sensitivity of PFTs for the detection of SSc-ILD, research is needed about how to increase rheumatologists’ HRCT ordering practices in their SSc patients.

Table 1: Baseline characteristics of the CONQUER cohort

Table 2: Univariate analyses

Table 3: Multivariable model


Disclosure: E. Bernstein, Boehringer Ingelheim, 2, 5; J. VanBuren, None; S. Assassi, Momenta, 1, corbus, 1, Integrity Continuing Education, 1, Boehringer Ingelheim, 1, 2, 3; F. Castelino, Boehringer Ingelheim, 5, 8; L. Chung, Eicos, 1, Reata, 1, Boehringer Ingelheim, 1, 2, Mitsubishi Tanabe, 1; C. Correia, Boehringer Ingelheim, 5, 8; L. Evnin, MPM Capital, 4, 9, Civi Biopharma, 1; T. Frech, None; E. Startup, None; J. Gordon, None; F. Hant, None; L. Hummers, Corbus Pharmaceuticals, 1, 2, Boehringer Ingelheim, 1, 2, CSL Behring, 1, 2, Cumberland Pharmaceuticals, 1, Medpace, 1, Glaxo Smith Kline, 1, Kadmon Corporation, 1; N. Sandorfi, None; A. Shah, None; V. Shanmugam, None; V. Steen, Boehringer Ingelheim, 2, 5, corbus, 2, 5, eicos, 2, 5, genetech, 2, forbius, 5, galapagos, 5; D. Khanna, Bayer, 2, BMS, 2, Horizon, 2, Pfizer, 2, NIH, 2, Immune Tolerance Network, 2, Eicos Sciences Inc, 4, Acceleron,, 5, Actelion,, 5, Abbvie,, 5, Amgen,, 5, Bayer,, 5, Boehringer Ingelheim, 5, CSL Behring, 5, Corbus,, 5, Galapagos,, 5, Genentech/Roche, 5, GSK, 5, Horizon, 5, Merck,, 5, Mitsubishi Tanabe Pharma, 5, Sanofi-Aventis, 5, United Therapeutics, 5, Impact PH, 9, Scleroderma Development, 6, CiviBioPharma/Eicos Sciences Inc, 6.

To cite this abstract in AMA style:

Bernstein E, VanBuren J, Assassi S, Castelino F, Chung L, Correia C, Evnin L, Frech T, Startup E, Gordon J, Hant F, Hummers L, Sandorfi N, Shah A, Shanmugam V, Steen V, Khanna D. Chest CT Ordering Practices at Expert Scleroderma Centers in the United States [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/chest-ct-ordering-practices-at-expert-scleroderma-centers-in-the-united-states/. Accessed April 11, 2021.
  • Tweet
  • Email
  • Print
Save to PDF

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/chest-ct-ordering-practices-at-expert-scleroderma-centers-in-the-united-states/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.